Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [4199]

SABCS 2015: DCIS patients receiving anastrozole reported symptoms different from those receiving tamoxifen both groups reported similar quality of life

SABCS 2015: DCIS patients receiving anastrozole reported symptoms different from those receiving tamoxifen both...

Delaying surgery after breast cancer diagnosis may lower survival rate

Delaying surgery after breast cancer diagnosis may lower survival rate

SABCS 2015: Eribulin mode of action and potential combos ID'd

SABCS 2015: Eribulin mode of action and potential combos ID'd

Delaying chemotherapy in breast cancer patients reduces overall survival, especially for those with triple-negative breast cancer

Delaying chemotherapy in breast cancer patients reduces overall survival, especially for those with triple...

SABCS 2015: Breast-conserving therapy yielded better outcomes than mastectomy for early-stage patients

SABCS 2015: Breast-conserving therapy yielded better outcomes than mastectomy for early-stage patients

SABCS 2015: Mastectomy plus reconstruction has higher complication rates and costs than lumpectomy plus radiation

SABCS 2015: Mastectomy plus reconstruction has higher complication rates and costs than lumpectomy plus radiation

SABCS 2015: Resistance of ER-positive breast cancer to tamoxifen therapy may be driven by APOBEC3B

SABCS 2015: Resistance of ER-positive breast cancer to tamoxifen therapy may be driven by APOBEC3B

SABCS 2015: Adding carboplatin to presurgery chemo improved disease-free survival for patients with TNBC

SABCS 2015: Adding carboplatin to presurgery chemo improved disease-free survival for patients with TNBC

Drugs prevent heart damage during breast cancer treatment, study shows

Drugs prevent heart damage during breast cancer treatment, study shows

SABCS 2015: Promising phase 1 results lead to phase 2 for ONT-380 in HER2 breast cancer

SABCS 2015: Promising phase 1 results lead to phase 2 for ONT-380 in HER2 breast cancer

More from ecancer